Ambulatory surgery in a pediatric patient with polycythemia Vera [PDF]
Claude Abdallah
openalex +1 more source
Supplementary Table from <i>In Vivo</i> Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target [PDF]
Shohei Murakami +16 more
openalex +1 more source
Hemangioblastoma: An Uncommon Cause of Polycythemia in a Child
Polycythemia is a rare condition in children. Myeloproliferative neoplasms, including polycythemia vera although rare, is an important cause of childhood primary polycythemia.
Surabhi Aryal, Arun Kumar Sharma
doaj +1 more source
Influència de l'haplotip 46/1 del gen JAK2 en la variació de la càrrega al·lèlica de la mutació JAK2V617F en pacients amb policitèmia vera i trombocitèmia esencial [PDF]
La presència de l'haplotip 46/1 del gen JAK2 predisposa a neoplàsies mieloproliferatives associades a la mutació de JAK2V617F, però la seva rellevància clínica és desconeguda.
Angona i Figueras, Anna +3 more
core
Treatment of Polycythemia Vera: Use of 32P Alone or in Combination With Maintenance Therapy Using Hydroxyurea in 461 Patients Greater Than 65 Years of Age [PDF]
Y Najean, Jean‐Didier Rain
openalex +1 more source
Polycythemia vera (PV) is mainly characterized by erythrocytosis, thrombotic and hemorrhagic predisposition, a variety of symptoms, and cumulative risks of fibrotic progression and/or leukemic evolution over time. The diagnosis is made based on the 2016 WHO criteria.
Gilberto, Barranco-Lampón +79 more
openaire +4 more sources
Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera [PDF]
Holger Cario +10 more
openalex +1 more source
Neutralize the neutrophils! Neutrophil β1 /β2 integrin activation contributes to JAK2-V617F–driven thrombosis [PDF]
Barbui +4 more
core +2 more sources
OUTCOME OF PATIENT WITH POLYCYTHEMIA VERA WITH PSYCHIATRIC SYMPTOMS
Rodrigo Coelho +3 more
openalex +1 more source

